Content coming soon.
BioVie Inc. has announced the pricing of a $4.74 million registered direct offering along with a concurrent private placement, both priced at-the-market under Nasdaq rules. This capital raise aims to support the company's ongoing development efforts and provide additional liquidity.
Summarize with
Key Points
- BioVie is raising $4.74 million through a registered direct offering.
- There is a concurrent private placement part of the financing, both priced at-the-market.
- The offering is structured under Nasdaq rules to support company plans.
Risks
- Market volatility could affect the success of the offering and future share price.
- Potential dilution of existing shareholders due to new share issuance.
- Uncertainty regarding the use of proceeds and impact on future financial results.